Search

Your search keyword '"Jaltotage, Biyanka"' showing total 21 results
Start Over Author "Jaltotage, Biyanka" Publication Year Range Last 10 years
21 results on '"Jaltotage, Biyanka"'

9. Artificial Intelligence in Cardiology: An Australian Perspective

Author

Jaltotage, Biyanka, primary, Ihdayhid, Abdul Rahman, additional, Lan, Nick S.R., additional, Pathan, Faraz, additional, Patel, Sanjay, additional, Arnott, Clare, additional, Figtree, Gemma, additional, Kritharides, Leonard, additional, Shamsul Islam, Syed Mohammed, additional, Chow, Clara K., additional, Rankin, James M., additional, Nicholls, Stephen J., additional, and Dwivedi, Girish, additional

Published
2023
Full Text
View/download PDF

14. Hepatic fat as a novel marker for high-risk coronary atherosclerosis in familial hypercholesterolaemia: a CT-based study

Author

Huangfu, Gavin, primary, Jaltotage, Biyanka, additional, Pang, Jing, additional, Lan, Nick, additional, Abraham, Arun, additional, Otto, Jacobus, additional, Ihdayhid, Abdul, additional, Rankin, Jamie, additional, Chow, Benjamin, additional, Watts, Gerald, additional, Dwivedi, Girish, additional, and Ayonrinde, Oyekoya, additional

Published
2022
Full Text
View/download PDF

21. The Utility of Circulating and Imaging Biomarkers Alone and in Combination in Heart Failure.

Author

Jaltotage B, Dwivedi G, Ooi DEL, and Mahadavan G

Subjects
Biomarkers, Hospitalization, Humans, Heart Failure diagnostic imaging
Abstract

Clinical trials in the treatment of heart failure have relied on the use of a composite of hard clinical endpoints to evaluate the efficacy of the treatment arm. This has led to prolonged trials requiring large patient cohorts and extensive funding to reach statistical significance. In this paper, we have explored the potential of currently available circulating and imaging biomarkers associated with heart failure as a surrogate for hard clinical end points in clinical trials. This would be expected to result in shorter trials, smaller patient cohorts and limited funding required. We have subsequently theorized on combining circulating and imaging biomarkers as a surrogate for clinical end points such as hospitalization from heart failure and cardiac mortality., (Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.)

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results